Last reviewed · How we verify

NCT07105462: ADRRPs

The Effects of Rotational Prisms on Badminton Players' Ocular Vergence Training and Enhancement of Shot Accuracy

Completed NA Last updated 6 August 2025
What this trial tests

NA trial testing Arm 1 - Experimental Group Intervention Name: ADRRPs Vergence Training Intervention Description: Participants wore an Automatic Dual Rotational Risley Prism (ADRRPs) headset to perform vergence eye in Eye Movements in 26 participants. Completed in 30 May 2025.

Timeline
24 March 2025
Primary endpoint
30 May 2025
30 May 2025

Quick facts

Lead sponsorChina Medical University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment26
Start date24 March 2025
Primary completion30 May 2025
Estimated completion30 May 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

China Medical University Hospital

Who can join

Adults 18 to 25, any sex, with Eye Movements or Visual Perception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial is designed to investigate whether a novel visual training system can improve eye coordination, reaction time, and hitting accuracy in competitive badminton players. The training utilizes a device called the Automatic Dual Rotational Risley Prisms (ADRRPs), which presents alternating base-in and base-out prism demands to stimulate vergence eye movements. This type of training aims to enhance the eyes' ability to converge and diverge quickly and accurately-a function that is important for visual clarity and motor performance during fast-paced sports. A total of 26 collegiate badminton athletes aged 18 to 25 years will be recruited from two universities in Taiwan. Participants will be randomly assigned to one of two groups: a visual training group using the active ADRRPs system, and a control group using a sham version of the same device containing plano lenses (with no prism effect). Training will be delivered twice per week for four weeks, with each session lasting 15 minutes. During each session, participants will view a video while the device applies alternating prism stimulation based on each individual's pre-measured fusional vergence capacity. Outcome measures will be assessed at baseline and after the four-week training period. These include vergence facility (cycles per minute), accommodative facility (flipper test), near point of convergence, and positive fusional vergence at near. Reaction time will be measured using a light-based agility task with BlazePod sensors, and hitting performance will be evaluated using a shuttlecock launcher that delivers randomized targets to various court zones. All participants will be monitored for any adverse events, and any symptoms such as diplopia, dizziness, or discomfort will be documented. Data will be analyzed as described in the Statistical Analysis Plan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Eye Movements

Currently open trials in the same condition.

Other China Medical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07105462.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing